Elem Biotech
Elem Biotech operates as a biotechnology company.
Pre Seed ·
Amount not disclosed in a source on record.
Funding history ↓About Elem Biotech
Recent Funding lists Elem Biotech under Health and bio. Its latest known round is a Pre Seed round (October 2026); no sourced amount is on record for it yet. Investors on record for it include Hangzhou Runmiao Fund, Highlight Capital and Xinghua Dingli.
Funding rounds
- Pre Seed · amount undisclosedSource: 163.com
- Website created
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
Other companies backed by Highlight Capital
RRgenta Therapeutics$52M Series A · Nov 2022
EEdgeRockSeries A · Oct 2026
Questions and sources
Elem Biotech: questions and answers
- Who invested in Elem Biotech?
- Investors on record for Elem Biotech: Hangzhou Runmiao Fund, Highlight Capital and Xinghua Dingli. Highlight Capital led a round.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/elem-biotech (get a free API key).